VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MDT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MDTMedtronic plc
$80.98$104.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMDTQuarterly Financials

Medtronic plc (MDT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Medtronic plc (MDT) quarterly income statement — complete revenue, gross profit & net income history

MDT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24
Sales/Revenue9.81B9.02B8.96B8.58B8.93B8.29B8.4B7.92B8.59B8.09B7.98B7.7B
Revenue Growth %9.86%8.76%6.64%8.38%3.94%2.51%5.25%2.77%0.53%4.68%5.26%4.49%
Cost of Goods Sold2.37B3.17B3.56B3.63B3.15B2.78B2.95B2.76B3.04B2.78B2.76B2.63B
COGS % of Revenue24.14%35.11%39.68%42.34%35.25%33.51%35.06%34.88%35.44%34.39%34.58%34.12%
Gross Profit7.44B5.85B5.41B4.95B5.78B5.51B5.46B5.15B5.54B5.31B5.22B5.07B
Gross Margin %75.87%64.88%60.32%57.66%64.75%66.49%64.94%65.12%64.56%65.61%65.42%65.88%
Gross Profit Growth %28.74%6.13%-0.95%-4.04%4.24%3.88%4.48%1.58%-0.38%5.34%3.43%4.51%
Operating Expenses5.88B4.08B3.72B3.5B4.34B3.87B3.86B3.88B4.49B3.82B3.88B3.81B
OpEx % of Revenue59.96%45.22%41.51%40.81%48.66%46.64%45.96%48.97%52.3%47.27%48.63%49.42%
Selling, General & Admin3.06B2.96B2.97B2.81B2.72B2.72B2.76B2.65B2.77B2.67B2.69B2.61B
SG&A % of Revenue31.17%32.77%33.1%32.71%30.47%32.77%32.81%33.54%32.19%33.04%33.64%33.93%
Research & Development671M722M754M726M684M675M697M676M675M695M698M668M
R&D % of Revenue6.84%8.01%8.41%8.46%7.66%8.14%8.29%8.54%7.86%8.59%8.74%8.67%
Other Operating Expenses1000K1000K0-1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income1.56B1.77B1.69B1.45B1.44B1.65B1.59B1.28B1.05B1.48B1.34B1.27B
Operating Margin %15.95%19.66%18.8%16.85%16.09%19.85%18.98%16.15%12.26%18.33%16.78%16.46%
Operating Income Growth %8.91%7.72%5.64%13.07%36.37%10.99%19.03%0.79%-32.72%6.54%-4.56%12.71%
EBITDA2.19B2.68B2.27B2.19B2.28B2.33B2.27B1.94B1.71B2.13B2.01B1.94B
EBITDA Margin %22.32%29.7%25.38%25.57%25.5%28.1%27.01%24.51%19.87%26.36%25.2%25.19%
EBITDA Growth %-3.82%14.94%0.18%13.04%33.33%9.29%12.82%0%-23.93%2.95%-3.04%8.2%
D&A (Non-Cash Add-back)625M905M589M748M840M684M675M662M654M649M672M672M
EBIT2.01B1.58B1.78B1.48B1.44B1.72B1.77B1.44B1.06B1.66B1.49B1.34B
Net Interest Income-331M-60M-181M-143M-174M-179M-209M-167M-202M-188M-180M-148M
Interest Income-154M121M033M00000000
Interest Expense177M181M181M176M174M179M209M167M202M188M180M148M
Other Income/Expense270M-369M-89M-143M-175M-106M-36M-10M-197M-11M-27M-72M
Pretax Income1.83B1.4B1.6B1.3B1.26B1.54B1.56B1.27B856M1.47B1.31B1.2B
Pretax Margin %18.7%15.57%17.81%15.18%14.13%18.57%18.55%16.02%9.97%18.2%16.45%15.53%
Income Tax575M254M215M255M199M237M281M220M197M135M402M400M
Effective Tax Rate %31.35%18.09%13.47%19.59%15.78%15.39%18.02%17.35%23.01%9.17%30.62%33.44%
Net Income1.24B1.14B1.37B1.04B1.06B1.29B1.27B1.04B654M1.32B909M791M
Net Margin %12.67%12.67%15.33%12.12%11.84%15.61%15.11%13.16%7.61%16.34%11.39%10.27%
Net Income Growth %17.6%-11.67%8.19%-0.19%61.62%-2.12%39.71%31.73%-44.53%8.18%112.88%-14.85%
Net Income (Continuing)1.26B1.15B1.38B1.05B1.06B1.3B1.28B1.05B659M1.34B911M797M
Discontinued Operations000000000000
Minority Interest609M211M204M240M232M228M222M213M206M204M187M188M
EPS (Diluted)0.960.891.070.810.821.010.990.800.490.990.680.59
EPS Growth %17.07%-11.88%8.08%1.25%67.35%2.02%45.59%35.59%-44.32%7.61%112.5%-15.71%
EPS (Basic)0.980.891.070.810.821.010.990.810.490.990.680.59
Diluted Shares Outstanding1.29B1.29B1.29B1.29B1.29B1.29B1.29B1.3B1.33B1.33B1.33B1.33B
Basic Shares Outstanding1.28B1.28B1.28B1.28B1.28B1.28B1.28B1.29B1.32B1.33B1.33B1.33B
Dividend Payout Ratio73.05%79.7%66.23%87.5%84.86%69.32%70.63%86.18%139.6%69.36%100.99%116.06%